Market for some cancer meds aims for $27.3B; GSK, Colgate settle toothpaste-label fight;

 @FiercePharma: Bayer, J&J's clot-fighter Xarelto wins key FDA nod for stroke prevention in AF pts-but with a warning. News | Follow @FiercePharma

> Small-molecule cancer drug sales are expected to grow to $27.3 billion by 2015, up from $20.3 billion in 2010, according to a new report from Visiongain. Item

> Amgen ($AMGN) shares jumped by almost 5% on news that it plans to buy back $5 billion of its shares over the next 30 days, for between $54 and $60 per share. Story

> GlaxoSmithKline ($GSK) and Colgate settled their fight over rights to the stylized blob of toothpaste known as a "nurdle," depicted on both companies' packaging. News

> Pfizer's ($PFE) bladder drug Toviaz met its primary endpoint in a study of urinary urgency during the night in patients with overactive bladder. Release

> Allergan ($AGN) plans a $12 million, 400-job research facility in New Jersey, after state officials offered a 10-year, $17 million grant. Article

> Express Scripts and Medco Health Solutions cut the termination fee on their proposed merger to $650 million. Report

Biotech News

 @FierceBiotech: Blockbuster breakup: Amylin buys out Lilly's exenatide rights in $1.6B deal. News | Follow @FierceBiotech

 @JohnCFierce: Key AZ/Targacept depression drug flunks first Phase III test. Item | Follow @JohnCFierce

 @RyanMFierce: Medidata (SaaS clinical trials software) reports profits up in 3Q, 33 new customers, $MDSO up 2.04%. Release | Follow @RyanMFierce

 @MaureenFierce: Nabi will explore strategic options after its anti-smoking vaccine NicVAX failed in a second Phase III trial. Article | Follow @MaureenFierce

> Key AZ/Targacept depression drug flunks first Phase III test. News

> Blockbuster breakup: Amylin buys out Lilly's exenatide rights in $1.6B deal. Story

> Biotech's Biggest Spenders 2011. Report

Biotech Research News

> Eliminating 'senescent' cells in mice delayed age-related ailments. News

> Stem cell therapy for Parkinson's works wells in two animal models. Story

> Scripps breakthrough unlocks the potential of a promising cancer drug class. More

Manufacturing News

> Plant check reveals Genentech report flaw repeat. Article

> Pharma recalls up 54% in Q3. Item

> MedImmune cell-culture plant named facility of the year. News

And Finally... U.S. pediatricians write 10 million unnecessary antibiotic prescriptions a year, a new study found. Story

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.